C4 THERAPEUTICS INC (CCCC) Institutional Shareholders
C4 THERAPEUTICS INC (CCCC) is currently reported in institutional portfolios tracked by InsiderSet based on the latest available SEC Form 13F filings for the quarter ended June 30, 2026. The institutional investors covered on this page collectively reported approximately $220.32M in CCCC holdings during the latest filing period.
Morgan Stanley is currently the largest disclosed institutional shareholder of CCCC tracked by InsiderSet, reporting ownership valued at approximately $23.86M in its March 31, 2026 SEC Form 13F filing. Based on current market prices and the latest disclosed share count, the position is now estimated to be worth approximately $32.75M, representing an estimated gain of +37.26% since the filing period.
The top 10 institutional shareholders tracked on this page collectively account for approximately 63% of the total disclosed CCCC value among the investors covered in this analysis. Major shareholders include Morgan Stanley, Ra Capital Management, L.P., Bain Capital Life Sciences Investors, Llc, and several other long-term asset managers with concentrated positions in C4 THERAPEUTICS INC (CCCC).
This page ranks the largest institutional CCCC shareholders using publicly disclosed SEC Form 13F data, including reported values, estimated current holding values, portfolio allocation percentages, ownership concentration metrics, and historical holding changes across major hedge funds and investment firms.
Institutional Holders
124
Total Reported Value
$220.32M
Largest Holder
Morgan Stanley
Largest Position
$23.86M
Insider Transactions (90d)
5
Latest Filing Quarter
Q2 2026
New Institutional Positions
141
Funds Exiting Positions
0
| Name | Investor/Manager | Portfolio % | Quantity | Reported Balance | Current Estimated Value | Gain/loss Since Filing | Estimated Portfolio Performance |
|---|---|---|---|---|---|---|---|
| Morgan Stanley | 0.00% | 9,072,400 | $23,860,411 | $32,751,364 | +$8,890,953 | +37.26% | |
| Ra Capital Management, L.P. | 0.22% | 8,000,000 | $21,040,000 | $28,880,000 | +$7,840,000 | +37.26% | |
| Bain Capital Life Sciences Investors, Llc | 1.70% | 7,171,910 | $18,862,123 | $25,890,595 | +$7,028,472 | +37.26% | |
| Lynx1 Capital Management Lp | 2.91% | 6,998,902 | $18,407,112 | $25,266,036 | +$6,858,924 | +37.26% | |
| Wasatch Advisors Lp | 0.11% | 3,522,644 | $16,450,747 | $12,716,745 | -$3,734,002 | -22.70% | |
| Vanguard Capital Management Llc | 0.00% | 3,861,852 | $10,156,671 | $13,941,286 | +$3,784,615 | +37.26% | |
| Soleus Capital Management, L.P. | 0.41% | 3,803,942 | $10,004,367 | $13,732,231 | +$3,727,864 | +37.26% | |
| Two Sigma Investments, Lp | 0.01% | 3,035,634 | $7,983,717 | $10,958,639 | +$2,974,922 | +37.26% | |
| Citadel Advisors Llc | 0.00% | 2,511,015 | $6,603,969 | $9,064,764 | +$2,460,795 | +37.26% | |
| Renaissance Technologies LLC | Jim Simons | 0.01% | 2,461,815 | $6,474,573 | $8,887,152 | +$2,412,579 | +37.26% |
| Goldman Sachs Group Inc | 0.00% | 2,387,378 | $6,278,804 | $8,618,435 | +$2,339,631 | +37.26% | |
| Bank Of America Corp | 0.00% | 2,359,241 | $6,204,805 | $8,516,860 | +$2,312,055 | +37.26% | |
| Squadron Capital Management Llc | 2.37% | 2,250,000 | $5,917,500 | $8,122,500 | +$2,205,000 | +37.26% | |
| Blackrock, Inc. | 0.00% | 2,048,526 | $5,387,622 | $7,395,179 | +$2,007,557 | +37.26% | |
| Silverarc Capital Management, Llc | 0.59% | 1,911,785 | $5,027,995 | $6,901,544 | +$1,873,549 | +37.26% | |
| Congress Asset Management Co | 0.03% | 1,003,437 | $4,686,051 | $3,622,408 | -$1,063,643 | -22.70% | |
| Millennium Management Llc | 0.00% | 1,393,342 | $3,664,489 | $5,029,965 | +$1,365,476 | +37.26% | |
| Susquehanna International Group, Llp | 0.00% | 1,286,840 | $3,384,389 | $4,645,492 | +$1,261,103 | +37.26% | |
| Jane Street Group, Llc | 0.00% | 1,246,896 | $3,279,336 | $4,501,295 | +$1,221,959 | +37.26% | |
| D. E. Shaw & Co., Inc. | 0.00% | 1,060,331 | $2,788,670 | $3,827,795 | +$1,039,125 | +37.26% | |
| Geode Capital Management, Llc | 0.00% | 951,043 | $2,502,399 | $3,433,265 | +$930,866 | +37.20% | |
| Wells Fargo & Company/Mn | 0.00% | 867,911 | $2,282,606 | $3,133,159 | +$850,553 | +37.26% | |
| Orbimed Advisors Llc | 0.05% | 856,353 | $2,252,208 | $3,091,434 | +$839,226 | +37.26% | |
| Qube Research & Technologies Ltd | 0.00% | 752,114 | $1,978,060 | $2,715,132 | +$737,072 | +37.26% | |
| Vanguard Fiduciary Trust Co | 0.00% | 484,131 | $1,273,265 | $1,747,713 | +$474,448 | +37.26% | |
| Stempoint Capital Lp | 0.23% | 453,236 | $1,192,011 | $1,636,182 | +$444,171 | +37.26% | |
| Charles Schwab Investment Management Inc | 0.00% | 452,228 | $1,189,360 | $1,632,543 | +$443,183 | +37.26% | |
| Dimensional Fund Advisors Lp | 0.00% | 442,518 | $1,160,181 | $1,597,490 | +$437,309 | +37.69% | |
| Platinum Investment Management Ltd | 0.26% | 384,766 | $1,011,935 | $1,389,005 | +$377,070 | +37.26% | |
| State Street Corp | 0.00% | 382,973 | $1,007,219 | $1,382,533 | +$375,314 | +37.26% | |
| Barclays Plc | 0.00% | 317,877 | $836,017 | $1,147,536 | +$311,519 | +37.26% | |
| 683 Capital Management, Llc | 0.07% | 300,000 | $789,000 | $1,083,000 | +$294,000 | +37.26% | |
| Connor, Clark & Lunn Investment Management Ltd. | 0.00% | 277,183 | $728,991 | $1,000,631 | +$271,640 | +37.26% | |
| Fmr Llc | 0.00% | 272,368 | $716,327 | $983,248 | +$266,921 | +37.26% | |
| Jacobs Levy Equity Management, Inc | 0.00% | 264,620 | $695,951 | $955,278 | +$259,327 | +37.26% | |
| Susquehanna Portfolio Strategies, Llc | 0.01% | 260,279 | $684,534 | $939,607 | +$255,073 | +37.26% | |
| Man Group Plc | 0.00% | 256,468 | $674,511 | $925,849 | +$251,338 | +37.26% | |
| Lpl Financial Llc | 0.00% | 246,800 | $649,084 | $890,948 | +$241,864 | +37.26% | |
| Invesco Ltd. | 0.00% | 244,507 | $643,053 | $882,670 | +$239,617 | +37.26% | |
| Ubs Group Ag | 0.00% | 215,877 | $567,756 | $779,316 | +$211,560 | +37.26% | |
| Walleye Capital Llc | 0.00% | 115,125 | $537,634 | $415,601 | -$122,033 | -22.70% | |
| Alps Advisors Inc | 0.00% | 112,214 | $524,039 | $405,093 | -$118,946 | -22.70% | |
| Bnp Paribas Financial Markets | 0.00% | 190,348 | $500,615 | $687,156 | +$186,541 | +37.26% | |
| Northern Trust Corp | 0.00% | 189,479 | $498,330 | $684,019 | +$185,689 | +37.26% | |
| Toronto Dominion Bank | 0.00% | 174,663 | $459,364 | $630,533 | +$171,169 | +37.26% | |
| Point72 Asset Management, L.P. | 0.00% | 169,096 | $444,722 | $610,437 | +$165,715 | +37.26% | |
| Marshall Wace, Llp | 0.00% | 155,495 | $408,952 | $561,337 | +$152,385 | +37.26% | |
| Vienna Powszechne Towarzystwo Emerytalne S.A. Vienna Insurance Group | 0.10% | 85,000 | $396,950 | $306,850 | -$90,100 | -22.70% | |
| Atom Investors Lp | 0.03% | 136,047 | $357,804 | $491,130 | +$133,326 | +37.26% | |
| Canada Pension Plan Investment Board | 0.00% | 135,600 | $356,628 | $489,516 | +$132,888 | +37.26% |
Frequently asked questions about CCCC
Who owns the most CCCC stock?
The largest holders of CCCC are typically major institutional investors such as asset managers and hedge funds reporting on Form 13F. The table above ranks tracked superinvestors by reported position size using the latest available filings for C4 THERAPEUTICS INC (CCCC).
Is CCCC widely held by superinvestors?
Many widely followed stocks like CCCC appear across numerous superinvestor portfolios because of liquidity, index inclusion, and fundamentals. The holder count and table above show how broadly CCCC is represented among the institutional managers we track.
What do “Current Estimated Value”, “Gain/loss Since Filing”, and “Estimated Portfolio Performance” mean?
Current Estimated Value is reported share quantity from the latest 13F times our most recent split-adjusted U.S. session close. Gain/loss Since Filing is that estimate minus the reported 13F dollar value; Estimated Portfolio Performance is that difference as a percent of the reported value. Green means the estimate is above the filing value; red means below (not purchase cost). If many filers share the same implied filing price per share, the performance % may match across rows. These are not official fund marks or live quotes.